Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 160

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 160
---
. |

Nominating and Corporate Governance Committee The nominating and corporate governance committee consists of Dr. Eun Sook Lee, Dr. Ji Yeon Baek and Nicholas Fernandez. The chair of the nominating and corporate governance committee is Nicholas Fernandez. The ParentCo Board has determined that each member of the nominating and corporate governance committee is independent under the Nasdaq listing standards. Specific responsibilities of the nominating and corporate governance committee include:

| ● | identifying and evaluating candidates, including the nomination of incumbent directors for re-election and nominees recommended by stockholders, to serve on the ParentCo Board; |

| ● | considering and making recommendations to the ParentCo Board regarding the composition and chairmanship of the committees of the ParentCo Board; |

| ● | developing and making recommendations to the ParentCo Board regarding corporate governance guidelines and matters, including in relation to corporate social responsibility; and |

| ● | overseeing periodic evaluations of the performance of the ParentCo Board, including its individual directors and committees. |

Code of Ethics ParentCo has adopted a code of ethics that applies to all of its executive officers, directors and employees, including its principal executive officer, principal financial officer, principal accounting officer or controller or persons performing similar functions. The code of ethics is available on ParentCo’s website. In addition, ParentCo has posted on its website all disclosures that are required by law or the listing standards of Nasdaq concerning any amendments to, or waivers from, any provision of the Code of Ethics. The reference to the ParentCo website address does not constitute incorporation by reference of the information contained at or available through ParentCo’s website, and you should not consider it to be a part of this registration statement. Compensation Committee Interlocks and Insider Participation None of the intended members of ParentCo’s compensation committee has ever been an executive officer or employee of ParentCo. None of ParentCo’s executive officers currently serve, or has served during the last completed fiscal year, on the compensation committee or board of directors of any other entity that has one or more executive officers that will serve as a member of the ParentCo Board or compensation committee.

104

Non-Employee Director Compensation We do not intend to compensate our non-employee directors. Limitation on Liability and Indemnification of Directors and Officers The ParentCo Certificate of Incorporation limits a directors’ liability to the fullest extent permitted under the DGCL. The DGCL provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as directors, except for liability: